Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biological Cells as Therapeutic Delivery Vehicles

Trends in Pharmacological Sciences(2020)10.1016/j.tips.2020.11.008Source: DataRank Database

Biological Cells as Therapeutic Delivery Vehicles is a research paper published in Trends in Pharmacological Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 64 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access64 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 4.89)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Connor P. Healy,Shwan B. Javdan ORCID,Jonathan C. Emmons,Tara L. Deans ORCID,Lucas M. Bush

Live enrichment

PubMed:33342562 PMC:PMC7856260 OpenAlex:https://openalex.org/W3112196875

NIBIB NIH HHS

Grant: R21 EB025413

NCI NIH HHS

Grant: DP2 CA250006

National Science Foundation

Grant: 1554017

CAREER: Probing Stem Cell Differentiation With Synthetic Biology

National Institutes of Health

Grant: 1R21EB025413-01

Engineering novel delivery systems with synthetic biology

National Institutes of Health

Grant: 1DP2CA250006-01

Engineered platelets for the targeted destruction of circulating tumor cells

National Science Foundation

National Institutes of Health

Office of Naval Research

FWCI

4.89

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7856260

publisherhttps://api.elsevier.com/content/article/PII:S0165614720302637?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0165614720302637?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.tips.2020.11.008

Fields of Study

Cancer Research and TreatmentsGraphene and Nanomaterials ApplicationsNanoplatforms for cancer theranostics0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Pharmaceutical PreparationsDrug Delivery SystemsMesenchymal Stem Cell TransplantationMesenchymal Stem Cells

Keywords

Drug deliveryMesenchymal stem cellImmunogenicityTargeted drug deliveryStem cellReprogrammingCell therapyGene deliveryCellDrugBiologyImmunologyCell biologyPharmacologyImmune systemCell cultureTransfectionNanotechnologyMaterials scienceSynthetic BiologyTherapeutic CellsDrug Delivery SystemsPharmaceutical PreparationsMesenchymal Stem CellsMesenchymal Stem Cell Transplantation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being